COX-2 knockout mice showed enhanced anti-poly(I:C) interferon responses, suggesting that COX-2 inhibitors might be a potential anti-viral therapy via boosting of the endogenous anti-viral response when provided soon after infection [189]. Here, PTGS2 is linked to infection.